329 related articles for article (PubMed ID: 25999657)
1. Proteomics in cancer biomarkers discovery: challenges and applications.
Sallam RM
Dis Markers; 2015; 2015():321370. PubMed ID: 25999657
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
3. Application of capillary electrophoresis for the early diagnosis of cancer.
Yang Z; Sweedler JV
Anal Bioanal Chem; 2014 Jul; 406(17):4013-31. PubMed ID: 24668067
[TBL] [Abstract][Full Text] [Related]
4. Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
6. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
Corbo C; Cevenini A; Salvatore F
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
8. Proteomics for early detection of colorectal cancer: recent updates.
Alnabulsi A; Murray GI
Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
[TBL] [Abstract][Full Text] [Related]
9. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
Mohri Y; Toiyama Y; Kusunoki M
Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the complexity of the cancer proteome for diagnostic applications.
Hanash S; Taguchi A; Wang H; Ostrin EJ
Expert Rev Mol Diagn; 2016; 16(4):399-405. PubMed ID: 26694525
[TBL] [Abstract][Full Text] [Related]
12. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
13. Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.
Luo L; Dong LY; Yan QG; Cao SJ; Wen XT; Huang Y; Huang XB; Wu R; Ma XP
Asian Pac J Cancer Prev; 2014; 15(20):8529-38. PubMed ID: 25374164
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer proteomics, clinical and technological considerations.
Lehtiö J; De Petris L
J Proteomics; 2010 Sep; 73(10):1851-63. PubMed ID: 20685322
[TBL] [Abstract][Full Text] [Related]
15. Biomarker research with prospective study designs for the early detection of cancer.
Pesch B; Brüning T; Johnen G; Casjens S; Bonberg N; Taeger D; Müller A; Weber DG; Behrens T
Biochim Biophys Acta; 2014 May; 1844(5):874-83. PubMed ID: 24361552
[TBL] [Abstract][Full Text] [Related]
16. Proteomics in cancer research: Are we ready for clinical practice?
Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G
Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications.
Torres VM; Popovic L; Vaz F; Penque D
Methods Mol Biol; 2016; 1395():281-98. PubMed ID: 26910080
[TBL] [Abstract][Full Text] [Related]
18. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
19. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
20. ADAM Metalloprotease-Released Cancer Biomarkers.
Herrlich P; Herrlich A
Trends Cancer; 2017 Jul; 3(7):482-490. PubMed ID: 28718403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]